Davis Chaim 4
4 · AMERICAN BIO MEDICA CORP · Filed Apr 10, 2020
Insider Transaction Report
Form 4
Davis Chaim
Director
Transactions
- Award
Common Shares
2020-04-08$0.21/sh+7,751$1,628→ 205,100 total
Footnotes (3)
- [F1]7,751 restricted common shares were issued to Davis as compensation for his attendance at a telephonic meeting of the Board of Directors held on March 31, 2020. This stock issuance is in accordance with the director compensation structure approved by the Company's Board of Directors on March 22, 2018 (as indicated in the Company's Proxy Statement filed with the Commission on April 18, 2018).
- [F2]The volume weighted average price of the Company's common shares for the 10 days preceding the meeting date of March 31, 2020 was $0.2097 per share.
- [F3]This is the number of common shares directly held by Davis. It does not include 2,978,486 common shares in the name of Revach Fund, LP. (deemed to be indirectly held by Davis). Davis is a managing member of Revach Group, LLC which operates as the general partner for Revach Fund LP.